YU293481A - Process for obtaining indole derivatives - Google Patents

Process for obtaining indole derivatives

Info

Publication number
YU293481A
YU293481A YU02934/81A YU293481A YU293481A YU 293481 A YU293481 A YU 293481A YU 02934/81 A YU02934/81 A YU 02934/81A YU 293481 A YU293481 A YU 293481A YU 293481 A YU293481 A YU 293481A
Authority
YU
Yugoslavia
Prior art keywords
indole derivatives
obtaining
obtaining indole
derivatives
indole
Prior art date
Application number
YU02934/81A
Other languages
English (en)
Inventor
P E Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU293481A publication Critical patent/YU293481A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
YU02934/81A 1980-12-15 1981-12-14 Process for obtaining indole derivatives YU293481A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
YU293481A true YU293481A (en) 1984-10-31

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02934/81A YU293481A (en) 1980-12-15 1981-12-14 Process for obtaining indole derivatives

Country Status (22)

Country Link
US (1) US4363912A (fr)
EP (1) EP0054417B1 (fr)
JP (1) JPS57181082A (fr)
KR (1) KR830007552A (fr)
AR (1) AR229110A1 (fr)
AU (1) AU525296B2 (fr)
CA (1) CA1143737A (fr)
CS (1) CS228527B2 (fr)
DD (1) DD202290A5 (fr)
DE (1) DE3167879D1 (fr)
DK (1) DK552581A (fr)
ES (1) ES8308872A1 (fr)
FI (1) FI814003L (fr)
GR (1) GR76355B (fr)
IE (1) IE51949B1 (fr)
IL (1) IL64534A0 (fr)
NO (1) NO814264L (fr)
PH (1) PH17576A (fr)
PL (1) PL133634B1 (fr)
PT (1) PT74123B (fr)
YU (1) YU293481A (fr)
ZA (1) ZA818665B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
SK7522001A3 (en) 1998-03-31 2002-02-05 Inst For Pharm Discovery Inc Substituted indolealkanoic acids
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (fr) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Procedes pour abaisser les niveaux d'acide urique
DK1569899T3 (da) * 2002-12-10 2006-10-23 Wyeth Corp Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
WO2008012511A1 (fr) 2006-07-22 2008-01-31 Oxagen Limited Composés présentant une activité d'antagonistes crth2
CN101918360A (zh) * 2007-09-24 2010-12-15 阿勒根公司 具有1-磷酸-鞘氨醇(s1p)受体生物学活性的带芳基或者杂芳基基团的吲哚化合物
RS53142B (sr) * 2008-01-18 2014-06-30 Atopix Therapeutics Limited Jedinjenja koja imaju antagonističku aktivnost na crth2
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
US8168673B2 (en) * 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
US20100022613A1 (en) * 2008-01-22 2010-01-28 Oxagen Limited Compounds Having CRTH2 Antagonist Activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (fr) * 1966-02-11 1967-06-19
FR7337M (fr) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
DK552581A (da) 1982-06-16
CA1143737A (fr) 1983-03-29
EP0054417B1 (fr) 1984-12-19
AU7848881A (en) 1982-06-24
ES507960A0 (es) 1983-10-01
ZA818665B (en) 1982-10-27
DD202290A5 (de) 1983-09-07
US4363912A (en) 1982-12-14
AR229110A1 (es) 1983-06-15
FI814003A7 (fi) 1982-06-16
EP0054417A1 (fr) 1982-06-23
AU525296B2 (en) 1982-10-28
IE51949B1 (en) 1987-04-29
PL133634B1 (en) 1985-06-29
PH17576A (en) 1984-10-01
GR76355B (fr) 1984-08-06
NO814264L (no) 1982-06-16
KR830007552A (ko) 1983-10-21
PT74123B (en) 1983-12-19
IE812928L (en) 1982-06-15
PT74123A (en) 1982-01-01
IL64534A0 (en) 1982-03-31
FI814003L (fi) 1982-06-16
JPS57181082A (en) 1982-11-08
CS228527B2 (en) 1984-05-14
PL234253A1 (en) 1983-05-23
ES8308872A1 (es) 1983-10-01
DE3167879D1 (en) 1985-01-31

Similar Documents

Publication Publication Date Title
YU221681A (en) Process for obtaining n-arylbenzamide derivatives
YU43051B (en) Process for preparing 1-sulfo-2-oxo-azetidine derivatives
YU227181A (en) Process for obtaining 3-aryl-5-isothiazole derivatives
PT73186B (en) Process for preparing pyrazolopyrydazine derivatives
PT74123B (en) Process for preparing indole derivatives
YU236881A (en) Process for obtaining amine derivatives
YU98081A (en) Process for obtaining imidosulfamide derivatives
DE3160156D1 (en) Process for preparing vinylphosphonic-acid derivatives
YU84179A (en) Process for obtaining 2-aminopyridone derivatives
YU42592B (en) Process for preparing 3-amino-propoxyphenyl derivatives
PL234173A1 (en) Process for preparing novel benzodiazepine derivatives
YU81181A (en) Process for obtaining substituted derivatives
PT73113B (en) Process for preparing substituted phenoxy-aminopropanol derivatives
YU217582A (en) Process for obtaining azolyl-pentene derivatives
GB2116558B (en) Improved process for preparing indole
PT74153B (en) Process for preparing oxadiazolopyrimidine derivatives
YU85181A (en) Process for obtaining new ergoline derivatives
YU43419B (en) Process for obtaining new izoquinolinic derivatives
YU252981A (en) Process for obtaining 11-dodecene-1-yl derivatives
YU159481A (en) Process for preparing dibenzindole derivatives
YU42413B (en) Process for obtaining dephenylether derivatives
SG65486G (en) Process for preparing 16-hydroxy-17-aminoprepnane derivatives
PT73457A (en) Process for preparing heteroprostaglandin derivatives
YU246381A (en) Process for obtaining cephalexine derivatives
YU43799B (en) Process for obtaining new benzoyl-phenyl-piperidine derivatives